Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease.

Munro CA, Longmire CF, Drye LT, Martin BK, Frangakis CE, Meinert CL, Mintzer JE, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG; Depression in Alzheimer’s Disease Study–2 Research Group.

Am J Geriatr Psychiatry. 2012 Dec;20(12):1036-44. doi: 10.1097/JGP.0b013e31826ce4c5.

PMID:
23032478
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.

Lyketsos CG, DelCampo L, Steinberg M, Miles Q, Steele CD, Munro C, Baker AS, Sheppard JM, Frangakis C, Brandt J, Rabins PV.

Arch Gen Psychiatry. 2003 Jul;60(7):737-46.

PMID:
12860778
[PubMed - indexed for MEDLINE]
3.

Cognitive response to pharmacological treatment for depression in Alzheimer disease: secondary outcomes from the depression in Alzheimer's disease study (DIADS).

Munro CA, Brandt J, Sheppard JM, Steele CD, Samus QM, Steinberg M, Rabins PV, Lyketsos CG.

Am J Geriatr Psychiatry. 2004 Sep-Oct;12(5):491-8.

PMID:
15353387
[PubMed - indexed for MEDLINE]
4.

Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial.

Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Knapp M, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, Orrell M, O'Brien J, Poppe M, Thomas A, Walwyn R, Wilson K, Burns A.

Lancet. 2011 Jul 30;378(9789):403-11. doi: 10.1016/S0140-6736(11)60830-1. Epub 2011 Jul 19. Review.

PMID:
21764118
[PubMed - indexed for MEDLINE]
5.

Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)?

Drye LT, Martin BK, Frangakis CE, Meinert CL, Mintzer JE, Munro CA, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG; DIADS-2 Research Group.

Int J Geriatr Psychiatry. 2011 Jun;26(6):573-83. doi: 10.1002/gps.2565.

PMID:
20672243
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.

Weintraub D, Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG; DIADS-2 Research Group.

Am J Geriatr Psychiatry. 2010 Apr;18(4):332-40. doi: 10.1097/JGP.0b013e3181cc0333.

PMID:
20220589
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine.

Banerjee S, Hellier J, Romeo R, Dewey M, Knapp M, Ballard C, Baldwin R, Bentham P, Fox C, Holmes C, Katona C, Lawton C, Lindesay J, Livingston G, McCrae N, Moniz-Cook E, Murray J, Nurock S, Orrell M, O'Brien J, Poppe M, Thomas A, Walwyn R, Wilson K, Burns A.

Health Technol Assess. 2013 Feb;17(7):1-166. doi: 10.3310/hta17070.

PMID:
23438937
[PubMed - indexed for MEDLINE]
Free Article
8.

A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease.

Magai C, Kennedy G, Cohen CI, Gomberg D.

Am J Geriatr Psychiatry. 2000 Winter;8(1):66-74.

PMID:
10648297
[PubMed - indexed for MEDLINE]
9.

Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study.

Lyketsos CG, Sheppard JM, Steele CD, Kopunek S, Steinberg M, Baker AS, Brandt J, Rabins PV.

Am J Psychiatry. 2000 Oct;157(10):1686-9.

PMID:
11007727
[PubMed - indexed for MEDLINE]
11.

Change in cognitive functioning in depressed older adults following treatment with sertraline or nortriptyline.

Culang-Reinlieb ME, Sneed JR, Keilp JG, Roose SP.

Int J Geriatr Psychiatry. 2012 Aug;27(8):777-84. doi: 10.1002/gps.2783. Epub 2011 Sep 15.

PMID:
21919060
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Sertraline for the treatment of depression in Alzheimer disease.

Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Weintraub D, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG; DIADS-2 Research Group.

Am J Geriatr Psychiatry. 2010 Feb;18(2):136-45. doi: 10.1097/JGP.0b013e3181c796eb.

PMID:
20087081
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden.

Feldman H, Gauthier S, Hecker J, Vellas B, Emir B, Mastey V, Subbiah P; Donepezil MSAD Study Investigators Group.

J Am Geriatr Soc. 2003 Jun;51(6):737-44. Erratum in: J Am Geriatr Soc. 2003 Sep;51(9):1331.

PMID:
12757558
[PubMed - indexed for MEDLINE]
14.

Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial.

Keller MB, Kocsis JH, Thase ME, Gelenberg AJ, Rush AJ, Koran L, Schatzberg A, Russell J, Hirschfeld R, Klein D, McCullough JP, Fawcett JA, Kornstein S, LaVange L, Harrison W.

JAMA. 1998 Nov 18;280(19):1665-72.

PMID:
9831997
[PubMed - indexed for MEDLINE]
15.

Atomoxetine augmentation of cholinesterase inhibitor therapy in patients with Alzheimer disease: 6-month, randomized, double-blind, placebo-controlled, parallel-trial study.

Mohs RC, Shiovitz TM, Tariot PN, Porsteinsson AP, Baker KD, Feldman PD.

Am J Geriatr Psychiatry. 2009 Sep;17(9):752-9. doi: 10.1097/JGP.0b013e3181aad585.

PMID:
19700948
[PubMed - indexed for MEDLINE]
16.

Analysis of outcome in retrieved dropout patients in a rivastigmine vs placebo, 26-week, Alzheimer disease trial.

Farlow M, Potkin S, Koumaras B, Veach J, Mirski D.

Arch Neurol. 2003 Jun;60(6):843-8.

PMID:
12810489
[PubMed - indexed for MEDLINE]
17.

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group.

Rogers SL, Doody RS, Mohs RC, Friedhoff LT.

Arch Intern Med. 1998 May 11;158(9):1021-31.

PMID:
9588436
[PubMed - indexed for MEDLINE]
18.

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.

Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.

J Am Geriatr Soc. 2001 Dec;49(12):1590-9.

PMID:
11843990
[PubMed - indexed for MEDLINE]
19.

A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil.

Finkel SI, Mintzer JE, Dysken M, Krishnan KR, Burt T, McRae T.

Int J Geriatr Psychiatry. 2004 Jan;19(1):9-18.

PMID:
14716694
[PubMed - indexed for MEDLINE]
20.

Sertraline treatment of elderly patients with depression and cognitive impairment.

Devanand DP, Pelton GH, Marston K, Camacho Y, Roose SP, Stern Y, Sackeim HA.

Int J Geriatr Psychiatry. 2003 Feb;18(2):123-30.

PMID:
12571820
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk